Literature DB >> 16282638

Mutation of F417 but not of L418 or L420 in the lipid binding domain decreases the activity of triacylglycerol hydrolase.

Mustafa Alam1, Dean Gilham, Dennis E Vance, Richard Lehner.   

Abstract

Human triacylglycerol hydrolase (hTGH) has been shown to play a role in hepatic lipid metabolism. Triacylglycerol hydrolase (TGH) hydrolyzes insoluble carboxylic esters at lipid/water interfaces, although the mechanism by which the enzyme adsorbs to lipid droplets is unclear. Three-dimensional modeling of hTGH predicts that catalytic residues are adjacent to an alpha-helix that may mediate TGH/lipid interaction. The helix contains a putative neutral lipid binding domain consisting of the octapeptide FLDLIADV (amino acid residues 417-424) with the consensus sequence FLXLXXXn (where n is a nonpolar residue and X is any amino acid except proline) identified in several other proteins that bind or metabolize neutral lipids. Deletion of this alpha-helix abolished the lipolytic activity of hTGH. Replacement of F417 with alanine reduced activity by 40% toward both insoluble and soluble esters, whereas replacement of L418 and L420 with alanine did not. Another potential mechanism of increasing TGH affinity for lipid is via reversible acylation. Molecular modeling predicts that C390 is available for covalent acylation. However, neither chemical modification of C390 nor mutation to alanine affected activity. Our findings indicate that F417 but not L418, L420, or C390 participates in substrate hydrolysis by hTGH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282638     DOI: 10.1194/jlr.M500344-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization.

Authors:  Heather M Alger; J Mark Brown; Janet K Sawyer; Kathryn L Kelley; Ramesh Shah; Martha D Wilson; Mark C Willingham; Lawrence L Rudel
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

2.  Adipose tissue-specific ablation of Ces1d causes metabolic dysregulation in mice.

Authors:  Gang Li; Xin Li; Li Yang; Shuyue Wang; Yulin Dai; Baharan Fekry; Lucas Veillon; Lin Tan; Rebecca Berdeaux; Kristin Eckel-Mahan; Philip L Lorenzi; Zhongming Zhao; Richard Lehner; Kai Sun
Journal:  Life Sci Alliance       Date:  2022-04-22

3.  Characterization of desnutrin functional domains: critical residues for triacylglycerol hydrolysis in cultured cells.

Authors:  Robin E Duncan; Yuhui Wang; Maryam Ahmadian; Jennifer Lu; Eszter Sarkadi-Nagy; Hei Sook Sul
Journal:  J Lipid Res       Date:  2009-08-19       Impact factor: 5.922

Review 4.  Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis.

Authors:  Chi-Liang Eric Yen; Scot J Stone; Suneil Koliwad; Charles Harris; Robert V Farese
Journal:  J Lipid Res       Date:  2008-08-29       Impact factor: 5.922

5.  Structure-function analysis of diacylglycerol acyltransferase sequences from 70 organisms.

Authors:  Heping Cao
Journal:  BMC Res Notes       Date:  2011-07-21

6.  Two Predicted Transmembrane Domains Exclude Very Long Chain Fatty acyl-CoAs from the Active Site of Mouse Wax Synthase.

Authors:  Steffen Kawelke; Ivo Feussner
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

7.  Monoacylglycerol O-acyltransferase 1 (MGAT1) localizes to the ER and lipid droplets promoting triacylglycerol synthesis.

Authors:  Yoo Jeong Lee; Jae-Woo Kim
Journal:  BMB Rep       Date:  2017-07       Impact factor: 4.778

Review 8.  Carboxylesterases in lipid metabolism: from mouse to human.

Authors:  Jihong Lian; Randal Nelson; Richard Lehner
Journal:  Protein Cell       Date:  2017-07-04       Impact factor: 14.870

Review 9.  DAG tales: the multiple faces of diacylglycerol--stereochemistry, metabolism, and signaling.

Authors:  Thomas Oliver Eichmann; Achim Lass
Journal:  Cell Mol Life Sci       Date:  2015-07-08       Impact factor: 9.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.